Kera Capital Partners, Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2040353
SACRAMENTO, CA
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$235,074
-$223,101 QoQ
Shares Held
377
-36.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kera Capital Partners, Inc. holds $3,255,768 across 11 Biotechnology names. REGN ranks #6 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
6,351 | $719,949 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
2,297 | $553,508 | |
| 3 | KYTX |
Kyverna Therapeutics, Inc.
|
40,000 | $356,400 | |
| 4 | FDMT |
4D Molecular Therapeutics, Inc.
|
24,068 | $320,104 | |
| 5 | PHAT |
Phathom Pharmaceuticals, Inc.
|
26,826 | $291,062 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
377 | $235,074 | |
| 7 | TECH |
BIO-TECHNE Corp
|
3,287 | $232,226 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
448 | $222,535 |
All Filings in REGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $235,074 | 377 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $458,175 | 593 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $366,638 | 475 | Shares | Sole | 2026-02-23 | |
| 2025-09-30 | $280,572 | 499 | Shares | Sole | 2025-10-27 | |
| No filing history on record for this holder in this stock. | ||||||